¿Adelantan el diagnóstico de la diabetes tipo 2 los nuevos criterios de la Asociación Americana de Diabetes?

Mata-Cases, Manel; Cos-Claramunt, Xavier; Ribera, Enriqueta Pujol; Molina, Israel; Fernández, Ramón; López, Ruy; Fuertes, A. Ramos; Pastor, C. Royo

doi:10.1016/s0212-6567(01)78890-7

Cited by 5 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Diagnostic criteria for CVRF were HbA1c > 7%; hypertension (blood pressure > 140/90 mmHg); hypercholesterolemia (total cholesterol > 250 mg/dL); hypertriglyceridemia (triglycerides > 150 mg/dL); obesity (BMI > 30 kg/m 2 ); and current or former smoking habit. Treatment goals for patients with and without a history of CVD were based on local guidelines [ 40 , 41 ]; without CVD prevention: HbA1c ≤ 7%, BP ≤ 140/90 mmHg, and LDL-cholesterol ≤ 130 mg/dL; with CVD prevention: HbA1c ≤ 7%, BP ≤ 140/90 mmHg, and LDL-cholesterol ≤ 100 mg/dL.…”

Section: Methodsmentioning

confidence: 99%

Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study

Franch-Nadal

Mata-Cases

Vinagre

et al. 2014

International Journal of Endocrinology

View full text Add to dashboard Cite

The objective of this cross-sectional study was to assess differences in the control and treatment of modifiable cardiovascular risk factors (CVRF: HbA1c, blood pressure [BP], LDL-cholesterol, body mass index, and smoking habit) according to gender and the presence of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) in Catalonia, Spain. The study included available data from electronic medical records for a total of 286,791 patients. After controlling for sex, age, diabetes duration, and treatment received, both men and women with prior CVD had worse cardiometabolic control than patients without previous CVD; women with prior CVD had worse overall control of CVRFs than men except for smoking; and women without prior CVD were only better than men at controlling smoking and BP, with no significant differences in glycemic control. Finally, although the proportion of women treated with lipid-lowering medications was similar to (with prior CVD) or even higher (without CVD) than men, LDL-cholesterol levels were remarkably uncontrolled in both women with and women without CVD. The results stress the need to implement measures to better prevent and treat CVRF in the subgroup of diabetic women, specifically with more intensive statin treatment in those with CVD.

show abstract

Section: Methodsmentioning

confidence: 99%

Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study

Franch-Nadal

Mata-Cases

Vinagre

et al. 2014

International Journal of Endocrinology

View full text Add to dashboard Cite

show abstract

Glicada para el diagnóstico de la diabetes, ¿un estándar universal?

Torres

2010

Atención Primaria

View full text Add to dashboard Cite

In August 2009, an ad hoc international expert committee created by the major world diabetic association, published an eagerly awaited consensus. In this, it recommended the general use of the haemoglobin A1c fraction for the diagnosis of diabetes, encouraging its standardisation and proposing a 6.5% cut-off. In this article, the diagnostic methods for diabetes, as well as the advantages, limitations and controversies of this new recommendation are reviewed.

show abstract

¿Cuál es el verdadero riesgo cardiovascular de los diabéticos?

Díez¹,

Martínez²,

Pérez³

et al. 2002

Atención Primaria

View full text Add to dashboard Cite

¿Adelantan el diagnóstico de la diabetes tipo 2 los nuevos criterios de la Asociación Americana de Diabetes?

Abstract: Not performing the OGTT means a delay in diagnosis which can be countered by applying the ADA criteria.

Cited by 5 publications

References 24 publications

Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study

Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study

Glicada para el diagnóstico de la diabetes, ¿un estándar universal?

¿Cuál es el verdadero riesgo cardiovascular de los diabéticos?

Contact Info

Product

Resources

About